Literature DB >> 21345624

Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection.

Lynn E Sullivan1, Joseph L Goulet, Amy C Justice, David A Fiellin.   

Abstract

BACKGROUND: The impact of alcohol consumption on depressive symptoms over time among patients who do not meet criteria for alcohol abuse or dependence is not known.
OBJECTIVE: To evaluate the impact of varying levels of alcohol consumption on depressive symptoms over time in patients with and without HIV infection.
DESIGN: We used data from the Veterans Aging Cohort Study (VACS). We used generalized estimating equation models to assess the association of alcohol-related categories, as a fixed effect, on the time-varying outcome of depressive symptoms. PARTICIPANTS: VACS is a prospectively enrolled cohort study of HIV-infected patients and age-, race- and site-matched HIV uninfected patients. MAIN MEASURES: Hazardous, binge drinking, alcohol abuse and alcohol dependence were defined using standard criteria. Depressive symptoms were measured by the Patient Health Questionnaire (PHQ-9). KEY
RESULTS: Among the 2446 patients, 19% reported past but not current alcohol use, 50% non-hazardous drinking, 8% hazardous drinking, 14% binge drinking, and 10% met criteria for alcohol or dependence. At baseline, depressive symptoms were higher in hazardous and binge drinkers than in past and non-hazardous drinkers (OR=2.65; CI=1.50/4.69; p<.001) and similar to those with abuse or dependence. There was no difference in the association between alcohol-related category and depressive symptoms by HIV status (OR=0.99; CI=.83/1.18; p=.88). Hazardous drinkers were 2.53 (95% CI=1.34/4.81) times and binge drinkers were 2.14 (95% CI=1.49/3.07) times more likely to meet criteria for depression when compared to non-hazardous drinkers. The associations between alcohol consumption and depressive symptoms persisted over three years and were responsive to changes in alcohol-related categories.
CONCLUSIONS: HIV-infected and HIV-uninfected hazardous and binge drinkers have depressive symptoms that are more severe than non-hazardous and non-drinkers and similar to those with alcohol abuse or dependence. Patients who switch to a higher or lower level of drinking experience a similar alteration in their depressive symptoms. Interventions to decrease unhealthy alcohol consumption may improve depressive symptoms.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21345624      PMCID: PMC3113463          DOI: 10.1016/j.drugalcdep.2011.01.014

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  44 in total

1.  Medications for alcohol dependence--new vistas.

Authors:  H R Kranzler
Journal:  JAMA       Date:  2000 Aug 23-30       Impact factor: 56.272

2.  At-risk drinking in an HMO primary care sample: prevalence and health policy implications.

Authors:  M F Fleming; L B Manwell; K L Barry; K Johnson
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

3.  Audit-3 and audit-4: effectiveness of two short forms of the alcohol use disorders identification test.

Authors:  Antoni Gual; Lidia Segura; Montserrat Contel; Nick Heather; Joan Colom
Journal:  Alcohol Alcohol       Date:  2002 Nov-Dec       Impact factor: 2.826

Review 4.  Depression and HIV infection: impact on immune function and disease progression.

Authors:  Dean G Cruess; John M Petitto; Jane Leserman; Steven D Douglas; David R Gettes; Thomas R Ten Have; Dwight L Evans
Journal:  CNS Spectr       Date:  2003-01       Impact factor: 3.790

5.  The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study.

Authors:  Frank H Galvan; Eric G Bing; John A Fleishman; Andrew S London; Raul Caetano; M Audrey Burnam; Doug Longshore; Sally C Morton; Maria Orlando; Martin Shapiro
Journal:  J Stud Alcohol       Date:  2002-03

6.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

7.  Problem drinking and medication adherence among persons with HIV infection.

Authors:  R L Cook; S M Sereika; S C Hunt; W C Woodward; J A Erlen; J Conigliaro
Journal:  J Gen Intern Med       Date:  2001-02       Impact factor: 5.128

8.  Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection.

Authors:  Dwight L Evans; Thomas R Ten Have; Steven D Douglas; David R Gettes; Mary Morrison; Margaret S Chiappini; Priscilla Brinker-Spence; Carla Job; Delinda E Mercer; Yan Lin Wang; Dean Cruess; Benoit Dube; Erik A Dalen; Tiffany Brown; Russell Bauer; John M Petitto
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

9.  Major depression in 6050 former drinkers: association with past alcohol dependence.

Authors:  Deborah S Hasin; Bridget F Grant
Journal:  Arch Gen Psychiatry       Date:  2002-09

10.  Specialty training and specialization among physicians who treat HIV/AIDS in the United States.

Authors:  Bruce E Landon; Ira B Wilson; Neil S Wenger; Susan E Cohn; Carl J Fichtenbaum; Samuel A Bozzette; Martin F Shapiro; Paul D Cleary
Journal:  J Gen Intern Med       Date:  2002-01       Impact factor: 5.128

View more
  53 in total

Review 1.  Neuropsychiatric complications of aging with HIV.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  J Neurovirol       Date:  2012-05-30       Impact factor: 2.643

2.  Selective neurocognitive deficits and poor life functioning are associated with significant depressive symptoms in alcoholism-HIV infection comorbidity.

Authors:  Stephanie A Sassoon; Margaret J Rosenbloom; Rosemary Fama; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Psychiatry Res       Date:  2012-05-29       Impact factor: 3.222

Review 3.  Interventions to reduce alcohol use among HIV-infected individuals: a review and critique of the literature.

Authors:  Jennifer L Brown; Kelly S DeMartini; Jessica M Sales; Andrea L Swartzendruber; Ralph J DiClemente
Journal:  Curr HIV/AIDS Rep       Date:  2013-12       Impact factor: 5.071

4.  The Role of Alcohol-Related Behavioral Research in the Design of HIV Secondary Prevention Interventions in the Era of Antiretroviral Therapy: Targeted Research Priorities Moving Forward.

Authors:  Paul A Shuper
Journal:  AIDS Behav       Date:  2021-05-13

5.  Association Between Gabapentin Receipt for Any Indication and Alcohol Use Disorders Identification Test-Consumption Scores Among Clinical Subpopulations With and Without Alcohol Use Disorder.

Authors:  Christopher T Rentsch; David A Fiellin; Kendall J Bryant; Amy C Justice; Janet P Tate
Journal:  Alcohol Clin Exp Res       Date:  2019-02-03       Impact factor: 3.455

6.  The influence of depressive symptoms on alcohol use among HIV-infected Russian drinkers.

Authors:  T P Palfai; D M Cheng; S M Coleman; C Bridden; E Krupitsky; J H Samet
Journal:  Drug Alcohol Depend       Date:  2013-09-23       Impact factor: 4.492

7.  A Cross-Sectional Study of Depressive Symptoms and Risky Alcohol Use Behaviors Among HIV Primary Care Patients in New York City.

Authors:  Yasemin Algur; Jennifer C Elliott; Efrat Aharonovich; Deborah S Hasin
Journal:  AIDS Behav       Date:  2018-05

8.  Differential impact of types of social support in the mental health of formerly incarcerated Latino men.

Authors:  Miguel Muñoz-Laboy; Nicolette Severson; Ashley Perry; Vincent Guilamo-Ramos
Journal:  Am J Mens Health       Date:  2013-12-09

Review 9.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

Review 10.  The association between alcohol use and cardiovascular disease among people living with HIV: a systematic review.

Authors:  Natalie E Kelso; David S Sheps; Robert L Cook
Journal:  Am J Drug Alcohol Abuse       Date:  2015-07-30       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.